OptEase Vena Cava Filter 466F220BRecalls & reported problems
Cordis US Corp. · Class 2 · Implant
All models of OptEase Vena Cava Filter (3)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 8
- Deaths reported
- 0
- Injuries reported
- 8
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 20705032009420), received between Jul 17, 2020 and Oct 17, 2022 — classified as 8 injuries.
The most frequently reported specific device problem is “Unintended Movement” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Unintended Movement4
- Fracture3
- Migration2
- Adverse Event Without Identified Device or Use Problem1
- Difficult to Remove1
- Filling Problem1
- Positioning Problem1
- Therapeutic or Diagnostic Output Failure1
Patient problems
- Coagulation Disorder3
- Perforation of Vessels3
- Obstruction/Occlusion2
- Thrombosis/Thrombus2
- Device Embedded In Tissue or Plaque1
- Embolus1
- Internal Organ Perforation1
- Occlusion1
Recent adverse event reports
The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.
InjuryOct 17, 2022Fracture; Difficult to Remove; Migration; Fracture; Difficult to Remove; Migration
AS REPORTED BY THE LEGAL BRIEF, A PATIENT UNDERWENT PLACEMENT OF AN OPTEASE VENA CAVA FILTER. THE FILTER SUBSEQUENTLY MALFUNCTIONED AND CAUSED INJURY AND DAMAGE TO THE PATIENT, INCLUDING, BUT NOT LIMITED TO INFERIOR VENA CAVA (IVC) THROMBOSIS, FRACTURE OF THE FILTER AND PAIN. AS A DIRECT AND PROXIMATE RESULT OF THESE MALFUNCTIONS, THE PATIENT SUFFERED LIFE-THREATENING INJURIES AND DAMAGES AND REQUIRED EXTENSIVE MEDICAL CARE AND TREATMENT, INCLUDING MULTIPLE SURGERIES. AS A FURTHER PROXIMATE RESULT, THE PATIENT HAS SUFFERED AND WILL CONTINUE TO SUFFER SIGNIFICANT MEDICAL EXPENSES, AND PAIN AND SUFFERING AND OTHER DAMAGES.
Patient problems: Coagulation Disorder; Device Embedded In Tissue or Plaque; Obstruction/Occlusion; Thrombosis/Thrombus
MAUDE report 15614351 ↗InjuryJul 5, 2022Unintended Movement; Unintended Movement
AS REPORTED IN THE LEGAL BRIEF, A PATIENT UNDERWENT PLACEMENT OF AN OPTEASE VENA CAVA FILTER. THE FILTER SUBSEQUENTLY MALFUNCTIONED AND CAUSED INJURY AND DAMAGE TO THE PATIENT, INCLUDING, BUT NOT LIMITED TO THE SUPERIOR END OF THE FILTER IS AT THE T11-12 INTERSPACE (SUPRARENAL LOCATION). THE FILTER IS TILTED ANTERIORLY AND LATERALLY AT THE SUPERIOR END AND CONTACTS THE INFERIOR VENA CAVA (IVC WALL). THE FILTER IS TILTED POSTERIORLY AT THE INFERIOR END AND CONTACTS THE IVC WALL. ALL THE STRUTS OF THE FILTER PERFORATE THE IVC UP TO 5MM. TWO (2) ANTERIOR STRUTS PERFORATE THE IVC WALL BOTH 5MM AND CONTACT THE RIGHT HEPATIC LOBE. ONE (1) MEDIAL STRUT PERFORATES THE IVC WALL 5MM AND RESIDES WITHIN THE SOFT TISSUES. ONE (1) POSTERIOR STRUT PERFORATES THE IVC WALL 5MM AND CONTACTS THE RIGHT ADRENAL GLAND. ONE (1) POSTERIOR STRUT PERFORATES THE IVC WALL 5MM AND RESIDES WITHIN THE SOFT TISSUES. ONE (1) LATERAL STRUT PERFORATES THE IVC WALL 5MM AND CONTACTS THE RIGHT HEPATIC LOBE. AS A DIRECT AND PROXIMATE RESULT OF THESE MALFUNCTIONS, THE PATIENT SUFFERED LIFE-THREATENING INJURIES AND DAMAGES, AND REQUIRED EXTENSIVE MEDICAL CARE AND TREATMENT. AS A FURTHER PROXIMATE RESULT, THE PATIENT HAS S
Patient problems: Internal Organ Perforation; Perforation of Vessels
MAUDE report 14918782 ↗InjuryMay 27, 2022Positioning Problem; Unintended Movement; Unintended Movement
AS REPORTED IN THE LEGAL BRIEF, A PATIENT UNDERWENT PLACEMENT OF AN OPTEASE VENA CAVA FILTER. THE FILTER SUBSEQUENTLY MALFUNCTIONED AND CAUSED INJURY AND DAMAGES TO THE PATIENT, INCLUDING BUT NOT LIMITED TO FILTER PERFORATION. AS A DIRECT AND PROXIMATE RESULT, THE PATIENT SUFFERED LIFE-THREATENING INJURIES AND DAMAGES AND REQUIRED EXTENSIVE MEDICAL CARE AND TREATMENT. AS A FURTHER PROXIMATE RESULT, THE PATIENT HAS SUFFERED AND WILL SUFFER SIGNIFICANT MEDICAL EXPENSES, PAIN AND SUFFERING AND OTHER DAMAGES.
Patient problems: Coagulation Disorder; Perforation; Perforation of Vessels
MAUDE report 14522880 ↗InjuryMay 26, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AS REPORTED BY THE LEGAL TEAM, THE PATIENT UNDERWENT PLACEMENT OF THE OPTEASE VENA CAVA FILTER. THE FILTER SUBSEQUENTLY MALFUNCTIONED AND CAUSED INJURY AND DAMAGES TO THE PATIENT, INCLUDING, BUT NOT LIMITED TO, OCCLUSION THAT CAUSES INJURY AND DAMAGES TO THE PATIENT.
Patient problems: Coagulation Disorder; Obstruction/Occlusion
MAUDE report 14517424 ↗InjuryJan 6, 2022Unintended Movement; Unintended Movement
AS REPORTED IN THE LEGAL BRIEF A PATIENT UNDERWENT PLACEMENT OF AN OPTEASE VENA CAVA FILTER. THE FILTER SUBSEQUENTLY MALFUNCTIONED AND CAUSED INJURY AND DAMAGE TO THE PATIENT INCLUDING, BUT NOT LIMITED TO FILTER TILTING. AS A DIRECT AND PROXIMATE RESULT, THE PATIENT SUFFERED LIFE THREATENING INJURIES AND DAMAGES AND REQUIRED EXTENSIVE MEDICAL CARE AND TREATMENT. AS A FURTHER PROXIMATE RESULT, THE PATIENT HAS SUFFERED AND WILL SUFFER SIGNIFICANT MEDICAL EXPENSES, PAIN AND SUFFERING AND OTHER DAMAGES.
Patient problems: Unspecified Tissue Injury
MAUDE report 13176215 ↗InjuryJun 2, 2021Filling Problem; Therapeutic or Diagnostic Output Failure
THE PATIENT IS REPORTED TO HAVE A HISTORY OF DVT AND PRIOR TO THE INDEX PROCEDURE, RESULTS OF A BILATERAL LOWER EXTREMITY ULTRASOUND SHOWED A RECENT DVT WITHIN THE MID AND RIGHT LOWER SUPERFICIAL FEMORAL VEIN. PER THE OPERATIVE REPORT, THE RIGHT FEMORAL VEIN WAS PUNCTURED FOLLOWED BY PLACEMENT OF A SHEATH, AND A GUIDEWIRE AND CATHETER WERE USED TO SELECT THE RIGHT AND LEFT RENAL VEINS. DIGITAL SUBTRACTION ANGIOGRAPHY WAS USED TO OBTAIN A CAVOGRAM. AN OPTEASE VENA CAVA FILTER WAS PLACED BELOW THE LEVEL OF THE RENAL VEINS. CONTRAST INJECTION FOLLOWING PLACEMENT OF THE FILTER DEMONSTRATED APPROPRIATE POSITIONING. THERE WERE NO COMPLICATIONS. THE REVIEW OF THE ADDITIONAL MEDICAL RECORDS PROVIDED REVEALED THAT ABOUT THREE DAYS AFTER THE FILTER WAS IMPLANTED, THE PATIENT UNDERWENT AN ABDOMINAL ULTRASOUND. THE REPORT NOTED THAT THE GALLBLADDER HAD BEEN SURGICALLY REMOVED, IN ADDITION TO A HYPOECHOIC LESION ON THE LEFT LOBE OF THE LIVER (RELATED TO INJURY) AND A SIMPLE CYST WITHIN THE MIDPOLE OF THE RIGHT KIDNEY. APPROXIMATELY A MONTH AFTER THE FILTER WAS IMPLANTED, AN ABDOMINAL X-RAY WAS PERFORMED FOR PERSISTENT PAIN POST LAPAROTOMY FOR STAB WOUND, AND GASTRIC DISTENTION WAS OBSERVED.
Patient problems: Thrombosis/Thrombus
MAUDE report 11919094 ↗InjuryOct 12, 2020Fracture; Unintended Movement; Fracture; Unintended Movement
AS REPORTED BY THE LEGAL BRIEF, THE PATIENT UNDERWENT PLACEMENT OF A OPTEASE VENA CAVA FILTER. THE REPORT STATES THAT THE FILTER SUBSEQUENTLY MALFUNCTIONED AND CAUSED INJURY AND DAMAGE TO THE PATIENT INCLUDING, BUT NOT LIMITED TO FRACTURE, PERFORATION OF IVC, TILT, AND PERFORATION ABUTTING ORGAN. INFORMATION RECEIVED PER THE MEDICAL RECORDS INDICATE THAT THE FILTER WAS IMPLANTED PROPHYLACTICALLY PRIOR TO BARIATRIC SURGERY. THE PATIENT WAS TO HAVE A GASTRIC BYPASS PROCEDURE. A FILTER WAS IMPLANTED VIA THE PATIENT'S RIGHT INTERNAL JUGULAR VEIN. INITIALLY A G-2 FILTER (MANUFACTURER: BARD) WAS ADVANCED INTO THE PATIENT. THEN IT WAS DETERMINED THAT THIS WOULD NOT WORK AND THE G-2 FILTER WAS NOT DEPLOYED. IT WAS DETERMINED THAT AN OPTEASE FILTER WOULD BE USED. THE OPTEASE FILTER WAS ADVANCED AND DEPLOYED SUCCESSFULLY. AN ANGIOGRAM SHOWED THAT THE LOCATION OF THE FILTER WAS APPROPRIATE. IT WAS 3 CM DISTAL TO THE LOWEST RENAL VEIN ON THE RIGHT SIDE. THERE WERE NO COMPLICATIONS. INFORMATION RECEIVED PER THE PATIENT PROFILE FORM (PPF) STATES THAT THE PATIENT EXPERIENCED FRACTURE WITHIN THE INFERIOR VENA CAVA (IVC) AND PERFORATION OF FILTER STRUTS OUTSIDE THE INFERIOR VENA CAVA (IVC) WITH THE
Patient problems: Perforation of Vessels
MAUDE report 10667465 ↗InjuryJul 17, 2020Fracture; Migration; Fracture; Migration
AS REPORTED BY THE LEGAL BRIEF, THE PATIENT UNDERWENT PLACEMENT OF A OPTEASE VENA CAVA FILTER. THE REPORT STATES THAT THE FILTER SUBSEQUENTLY MALFUNCTIONED AND CAUSED INJURY AND DAMAGE TO THE PATIENT INCLUDING, BUT NOT LIMITED TO FRACTURE, EMBEDMENT AND OCCLUSION. INFORMATION RECEIVED PER THE MEDICAL RECORDS INDICATE THAT THE PATIENT HAS A HISTORY OF DEEP VEIN THROMBOSIS IN LEFT LEG. THE PATIENT HAD A L5-S1 LAMINECTOMY APPROXIMATELY ONE MONTH PRIOR. THE FILTER WAS DEPLOYED VIA THE PATIENT'S RIGHT COMMON FEMORAL VEIN. IN ADDITION TO THE FILTER PLACEMENT PROCEDURE, THE PATIENT ALSO UNDERWENT LEFT ILIOFEMORAL THROMBECTOMY AND ANGIOPLASTY AND STENTING WITH TWO WALLSTENTS (14X90) FOR ILIOFEMORAL VENOUS STENOSIS THE SAME DAY. INFORMATION RECEIVED PER THE PATIENT PROFILE FORM (PPF) STATES THAT THE PATIENT EXPERIENCED FILTER FRACTURE WITHIN THE VENA CAVA AND THE RIGHT VENTRICULAR WALL, EMBEDDED, BLOOD CLOTS, CLOTTING, AND/OR OCCLUSION OF THE INFERIOR VENA CAVA (IVC). THERE WAS A REMOVAL ATTEMPT EIGHT YEARS AND EIGHT MONTHS AFTER THE INDEX PROCEDURE AND A SECOND REMOVAL ATTEMPT EIGHT YEARS AND TEN MONTHS AFTER THE INDEX PROCEDURE. FILTER FRAGMENTS REMAIN WITHIN THE PATIENT'S VENA CAVA AND R
Patient problems: Embolus; Occlusion; Vessel Or Plaque, Device Embedded In
MAUDE report 10289013 ↗
Other FILTER, INTRAVASCULAR, CARDIOVASCULAR devices
- Denali® Vena Cava Filter DL900FBard Peripheral Vascular, Inc. · FILTER, INTRAVASCULAR, CARDIOVASCULAR22 deaths529 reports
- DENALI® Vena Cava Filter DL900JBard Peripheral Vascular, Inc. · FILTER, INTRAVASCULAR, CARDIOVASCULAR15 deaths492 reports
- Option Elite Retrievable Vena Cava Filter System 352506070EArgon Medical Devices, Inc. · Filter, Intravascular, Cardiovascular2 recalls3 deaths342 reports
- Gunther Tulip G33016Cook Incorporated · FILTER, INTRAVASCULAR, CARDIOVASCULAR3 deaths348 reports
- Gunther Tulip G33017Cook Incorporated · FILTER, INTRAVASCULAR, CARDIOVASCULAR3 deaths286 reports
- Cook Celect G34309William Cook Europe ApS · FILTER, INTRAVASCULAR, CARDIOVASCULAR1 recall1 death230 reports
- Gunther Tulip G52916William Cook Europe ApS · FILTER, INTRAVASCULAR, CARDIOVASCULAR1 recall2 deaths189 reports
- Cook Celect G34502William Cook Europe ApS · FILTER, INTRAVASCULAR, CARDIOVASCULAR1 recall2 deaths165 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page